by Brian Cardillo | Jan 16, 2025 | News, Press Releases
WASHINGTON, D.C., JANUARY 16, 2025 – ATA Action is urging President Trump to immediately withdraw the Drug Enforcement Administration’s (DEA) draft Special Registration for Telemedicine and Limited State Telemedicine Registrations published this morning, making this a...
by Brian Cardillo | Jan 15, 2025 | News, Press Releases
WASHINGTON, D.C., JANUARY 15, 2025 – ATA Action provides initial response to the Special Registration for Telemedicine framework published this morning by the Drug Enforcement Administration (DEA) authorizing certain DEA-registered practitioners to engage in the...
by Brian Cardillo | Jan 14, 2025 | News, Press Releases
WASHINGTON, D.C., JANUARY 14, 2025 – This morning, ATA Action urged the Drug Enforcement Agency (DEA) to take immediate steps to form a public-private workgroup to establish a permanent framework for the remote prescribing of controlled substances. In a letter to DEA...
by Brian Cardillo | Dec 21, 2024 | News, Press Releases
Medicare telehealth flexibilities and the Acute Hospital Care at Home Program Extensions through March 2025 WASHINGTON, D.C., DECEMBER 21, 2024 – The American Telemedicine Association (ATA) and ATA Action respond to passage of a slimmed-down, short-term Continuing...
by Brian Cardillo | Nov 16, 2024 | News, Press Releases
WASHINGTON, D.C. NOVEMBER 15, 2024 – This afternoon, a third extension was officially posted to the Federal Register, granting the U.S. Drug Enforcement Administration (DEA) a clean, one-year extension of the remote prescribing of controlled substances. This critical...
